» Articles » PMID: 18317464

DISC1 Association, Heterogeneity and Interplay in Schizophrenia and Bipolar Disorder

Abstract

Disrupted in schizophrenia 1 (DISC1) has been associated with risk of schizophrenia, schizoaffective disorder, bipolar disorder, major depression, autism and Asperger syndrome, but apart from in the original translocation family, true causal variants have yet to be confirmed. Here we report a harmonized association study for DISC1 in European cohorts of schizophrenia and bipolar disorder. We identify regions of significant association, demonstrate allele frequency heterogeneity and provide preliminary evidence for modifying interplay between variants. Whereas no associations survived permutation analysis in the combined data set, significant corrected associations were observed for bipolar disorder at rs1538979 in the Finnish cohorts (uncorrected P=0.00020; corrected P=0.016; odds ratio=2.73+/-95% confidence interval (CI) 1.42-5.27) and at rs821577 in the London cohort (uncorrected P=0.00070; corrected P=0.040; odds ratio=1.64+/-95% CI 1.23-2.19). The rs821577 single nucleotide polymorphism (SNP) showed evidence for increased risk within the combined European cohorts (odds ratio=1.27+/-95% CI 1.07-1.51), even though significant corrected association was not detected (uncorrected P=0.0058; corrected P=0.28). After conditioning the European data set on the two risk alleles, reanalysis revealed a third significant SNP association (uncorrected P=0.00050; corrected P=0.025). This SNP showed evidence for interplay, either increasing or decreasing risk, dependent upon the presence or absence of rs1538979 or rs821577. These findings provide further support for the role of DISC1 in psychiatric illness and demonstrate the presence of locus heterogeneity, with the effect that clinically relevant genetic variants may go undetected by standard analysis of combined cohorts.

Citing Articles

Small Nucleolar RNAs and the Brain: Growing Evidence Supporting Their Role in Psychiatric Disorders.

Salles J, Lin R, Turecki G Biol Psychiatry Glob Open Sci. 2025; 5(2):100415.

PMID: 39867567 PMC: 11758842. DOI: 10.1016/j.bpsgos.2024.100415.


Crossroad between current knowledge and new perspective of diagnostic and therapy of late-onset schizophrenia and very late-onset schizophrenia-like psychosis: An update.

Stpien-Wyrobiec O, Nowak M, Wyrobiec G, Morawiec E, Wierzbik-Stronska M, Staszkiewicz R Front Psychiatry. 2022; 13:1025414.

PMID: 36387009 PMC: 9643586. DOI: 10.3389/fpsyt.2022.1025414.


Pathological oligodendrocyte precursor cells revealed in human schizophrenic brains and trigger schizophrenia-like behaviors and synaptic defects in genetic animal model.

Yu G, Su Y, Guo C, Yi C, Yu B, Chen H Mol Psychiatry. 2022; 27(12):5154-5166.

PMID: 36131044 PMC: 9763102. DOI: 10.1038/s41380-022-01777-3.


Markers of Schizophrenia-A Critical Narrative Update.

Galinska-Skok B, Waszkiewicz N J Clin Med. 2022; 11(14).

PMID: 35887728 PMC: 9323796. DOI: 10.3390/jcm11143964.


Combining fMRI and DISC1 gene haplotypes to understand working memory-related brain activity in schizophrenia.

Guardiola-Ripoll M, Sotero-Moreno A, Almodovar-Paya C, Hostalet N, Guerrero-Pedraza A, Ramiro N Sci Rep. 2022; 12(1):7351.

PMID: 35513527 PMC: 9072540. DOI: 10.1038/s41598-022-10660-8.